Following tamoxifen treatment, CCR2+ monocytes were adoptively transferred into 3T-FVB lung transplant recipients undergoing BOS pathogenesis (Figure 7F). This evidence concerns the gene CCR2 and Buschke-Ollendorff syndrome.